Learn the latest advancements in the understanding and management of IgA Nephropathy (IgAN) with two expert-led videos with Professors Brad Rovin, MD (United States) and Jürgen Floege, MD (Germany). In these videos, Dr. Rovin and Dr. Floege share their perspectives on cutting-edge research, innovative therapies, and the practical implications for improving outcomes for people with IgAN.
Dr. Rovin and Dr. Floege are currently co-chairing the forthcoming KDIGO 2025 IgA Nephropathy/IgA Vasculitis and Nephrotic Syndrome in Children Guidelines. They have also co-chaired the 2024 Lupus Nephritis and ANCA Vasculitis Guidelines and the 2021 Glomerular Diseases Guideline.
These videos, recorded in October 2024 in San Diego, California, offer valuable insights for healthcare professionals looking to stay informed on this rapidly evolving area of kidney care.
Updates in IgA Nephropathy – Part 1 with Dr. Brad Rovin
In this insightful video, Brad Rovin, MD (United States) discusses the latest updates in IgA nephropathy, focusing on advances in diagnosis, treatment, and patient care. Dr. Rovin highlights the evolving role of novel therapies, biomarkers, and patient-centered approaches in managing this complex kidney disease. Dr. Rovin’s expert perspective offers invaluable guidance for clinicians navigating this rapidly changing field.
Updates in IgA Nephropathy – Part 2 with Dr. Jürgen Floege
In this informative video, Jürgen Floege, MD (Germany) delves into the latest updates in IgA Nephropathy (IgAN), highlighting advancements in treatment strategies, emerging therapies, the role of prediction tools in disease prognosis, and the practical integration of research into clinical care. Dr. Floege addresses the challenges of global implementation, emphasizing how resource and cost constraints in some countries impact access to new therapies and explores strategies to optimize the use of older therapies to overcome these barriers. He also underscores the importance of early intervention and personalized, patient-centered approaches to managing IgAN. Dr. Floege’s expert insights offer invaluable guidance for clinicians navigating this complex kidney disease.
Learn more at NephU: https://nephu.org/iga-nephropathy/
These videos were made possible with support from Otsuka.
